IOVA vs. UWMC
IOVA (Iovance Biotherapeutics, Inc.) and UWMC (UWM Holdings Corporation) are both stocks. IOVA operates in Biotechnology (Healthcare), while UWMC operates in Mortgage Finance (Financial Services). Over the past 5 years, IOVA returned -26.71%/yr vs -14.78%/yr for UWMC. At a 0.29 correlation, their price movements are largely independent.
Performance
IOVA vs. UWMC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IOVA achieves a 38.83% return, which is significantly higher than UWMC's -35.94% return.
IOVA
- 1D
- -7.56%
- 1M
- -1.56%
- YTD
- 38.83%
- 6M
- 71.49%
- 1Y
- 108.24%
- 3Y*
- -24.48%
- 5Y*
- -26.71%
- 10Y*
- -7.92%
UWMC
- 1D
- -8.08%
- 1M
- -22.88%
- YTD
- -35.94%
- 6M
- -49.47%
- 1Y
- -27.57%
- 3Y*
- -13.32%
- 5Y*
- -14.78%
- 10Y*
- —
IOVA vs. UWMC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 38.83% | -63.11% | -8.98% | 27.23% | -66.53% | -39.91% |
UWMC UWM Holdings Corporation | -35.94% | -19.30% | -13.04% | 132.11% | -38.03% | -28.60% |
Correlation
The correlation between IOVA and UWMC is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2021 | 0.29 |
Fundamentals
IOVA:
$1.59B
UWMC:
$4.37B
IOVA:
-$0.93
UWMC:
$0.37
IOVA:
5.06
UWMC:
0.50
IOVA:
2.20
UWMC:
2.73
IOVA:
$285.61M
UWMC:
$3.10B
IOVA:
$327.04M
UWMC:
$1.79B
IOVA:
-$325.45M
UWMC:
$1.03B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IOVA vs. UWMC — Risk / Return Rank
IOVA
UWMC
IOVA vs. UWMC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and UWM Holdings Corporation (UWMC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IOVA | UWMC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.58 | ||
| Sortino ratioReturn per unit of downside risk | +2.63 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 0.95 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 2.00 | -0.48 | +2.48 |
| Martin ratioReturn relative to average drawdown | 3.14 | -0.99 | +4.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IOVA | UWMC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.07 | -0.51 | +1.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.30 | -0.29 | -0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.10 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | -0.27 | +0.14 |
Drawdowns
IOVA vs. UWMC - Drawdown Comparison
The maximum IOVA drawdown since its inception was -99.37%, which is greater than UWMC's maximum drawdown of -68.67%. Use the drawdown chart below to compare losses from any high point for IOVA and UWMC.
Loading charts...
Drawdown Indicators
| IOVA | UWMC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -68.67% | -30.70% |
Max Drawdown (1Y)Largest decline over 1 year | -54.41% | -57.91% | +3.50% |
Max Drawdown (3Y)Largest decline over 3 years | -90.50% | -67.19% | -23.31% |
Max Drawdown (5Y)Largest decline over 5 years | -93.99% | -68.67% | -25.32% |
Max Drawdown (10Y)Largest decline over 10 years | -96.84% | — | — |
Current DrawdownCurrent decline from peak | -97.62% | -67.19% | -30.43% |
Average DrawdownAverage peak-to-trough decline | -84.16% | -37.17% | -46.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.64% | 27.87% | +6.77% |
Volatility
IOVA vs. UWMC - Volatility Comparison
Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 24.33% compared to UWM Holdings Corporation (UWMC) at 11.81%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than UWMC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IOVA | UWMC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.33% | 11.81% | +12.52% |
Volatility (6M)Calculated over the trailing 6-month period | 62.96% | 39.51% | +23.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 101.64% | 54.13% | +47.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.79% | 50.73% | +39.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 81.28% | 50.72% | +30.56% |
Dividends
IOVA vs. UWMC - Dividend Comparison
IOVA has not paid dividends to shareholders, while UWMC's dividend yield for the trailing twelve months is around 14.65%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
UWMC UWM Holdings Corporation | 14.65% | 9.13% | 6.81% | 5.59% | 12.08% | 6.76% |
Financials
IOVA vs. UWMC - Financials Comparison
This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and UWM Holdings Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IOVA and UWMC have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IOVA has higher volatility (24.33%) compared to UWMC (11.81%). In terms of maximum drawdown, IOVA dropped -99.37% vs UWMC's -68.67%.
IOVA currently has the higher Sharpe Ratio (1.07 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IOVA and UWMC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer